Skip to main content
Journal cover image

Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease.

Publication ,  Journal Article
Longoria, JN; Pugh, NL; Gordeuk, V; Hsu, LL; Treadwell, M; King, AA; Gibson, R; Kayle, M; Crego, N; Glassberg, J; Melvin, CL; Hankins, JS; Porter, J
Published in: American journal of hematology
November 2021

Individuals with sickle cell disease (SCD) experience neurocognitive decline, low medication adherence, increased unemployment, and difficulty with instrumental activities of daily living (IADL). The relationship between self-perceived cognitive difficulties and IADLs, including employment, school enrollment, independence, engagement in leisure activities, and medication adherence is unknown. We hypothesized that self-reported difficulties across neurocognitive areas would predict lower IADL skills. Adolescent and adult participants of the multi-site Sickle Cell Disease Implementation Consortium (SCDIC) (n = 2436) completed patient-reported outcome (PRO) measures of attention, executive functioning, processing speed, learning, and comprehension. Cognitive symptoms were analyzed as predictors in multivariable modeling. Outcome variables included 1) an IADL composite that consisted of employment, participation in school, reliance on others, and leisure pursuits, and 2) hydroxyurea adherence. Participants reported cognitive difficulty across areas of attention (55%), executive functioning (51%), processing speed (57%), and reading comprehension (65%). Executive dysfunction (p < 0.001) and sometimes or often experiencing learning difficulties (p < 0.001 and p = 0.04) and poor comprehension (p = 0.000 and p = 0.001), controlled for age (p < 0.001), pain (p < 0.001), and hydroxyurea use (p = 0.001), were associated with poor IADL skills. Executive functioning difficulties (p = 0.021), controlled for age (p = 0.013 for ages 25-34), genotype (p = 0.001), and hemoglobin (p = 0.004), predicted hydroxyurea non-adherence. Analysis of PRO measures indicated that cognitive dysfunction is prevalent in adolescents and adults with SCD. Cognitive dysfunction translated into clinically meaningful outcomes. PRO of cognitive symptoms can be used as an important adjunct clinical tool to monitor symptoms that impact functional skills, including engagement in societal activities and medication adherence.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

American journal of hematology

DOI

EISSN

1096-8652

ISSN

0361-8609

Publication Date

November 2021

Volume

96

Issue

11

Start / End Page

1396 / 1406

Related Subject Headings

  • Young Adult
  • Middle Aged
  • Medication Adherence
  • Male
  • Immunology
  • Hydroxyurea
  • Humans
  • Female
  • Cognitive Dysfunction
  • Antisickling Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Longoria, J. N., Pugh, N. L., Gordeuk, V., Hsu, L. L., Treadwell, M., King, A. A., … Porter, J. (2021). Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease. American Journal of Hematology, 96(11), 1396–1406. https://doi.org/10.1002/ajh.26315
Longoria, Jennifer N., Norma L. Pugh, Victor Gordeuk, Lewis L. Hsu, Marsha Treadwell, Allison A. King, Robert Gibson, et al. “Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease.American Journal of Hematology 96, no. 11 (November 2021): 1396–1406. https://doi.org/10.1002/ajh.26315.
Longoria JN, Pugh NL, Gordeuk V, Hsu LL, Treadwell M, King AA, et al. Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease. American journal of hematology. 2021 Nov;96(11):1396–406.
Longoria, Jennifer N., et al. “Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease.American Journal of Hematology, vol. 96, no. 11, Nov. 2021, pp. 1396–406. Epmc, doi:10.1002/ajh.26315.
Longoria JN, Pugh NL, Gordeuk V, Hsu LL, Treadwell M, King AA, Gibson R, Kayle M, Crego N, Glassberg J, Melvin CL, Hankins JS, Porter J. Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease. American journal of hematology. 2021 Nov;96(11):1396–1406.
Journal cover image

Published In

American journal of hematology

DOI

EISSN

1096-8652

ISSN

0361-8609

Publication Date

November 2021

Volume

96

Issue

11

Start / End Page

1396 / 1406

Related Subject Headings

  • Young Adult
  • Middle Aged
  • Medication Adherence
  • Male
  • Immunology
  • Hydroxyurea
  • Humans
  • Female
  • Cognitive Dysfunction
  • Antisickling Agents